1 outlets · filed 6 November 2026
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
This story is from the archive. It was covered between
6 November 2026 and
6 November 2026, and nothing
below has been updated since. See what is happening now.
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
How it broke
CNBC
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.
